Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Patients suffering from high risk stage II colon cancer (CC) may benefit from adjuvant onco-therapy, but additional prognostic markers are needed for better treatment stratification. | Programmed Death Ligand-1 expression in stage II colon cancer - experiences from a nationwide populationbased cohort